Guidant Corporation   Report issue

For profit Phase 3 Phase 4
Founded: Marlborough MA United States (1994)
Status: Acquired by Boston Scientific Corporation (2006)

Organization Overview

First Clinical Trial
2004
NCT00279175
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (2)

clopidogrel (plavix) (1 trial)

tenecteplase (tnkase) (1 trial)

Drugs in Phase 3 Trials (1)

bone marrow derived mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3